MATINAS BIOPHARMA HOLDINGS, INC. Other Accrued Liabilities, Current
MATINAS BIOPHARMA HOLDINGS, INC. (MTNB) had Other Accrued Liabilities, Current of $39.00 thousand as of 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Notes › Payables and Accruals › Accrued Liabilities, Current
us-gaap:OtherAccruedLiabilitiesCurrent · last filed 2026-08-13
- 2026-06-30: Other Accrued Liabilities, Current $39.00K.
- 2025-12-31: Other Accrued Liabilities, Current $34.00K.
- 2025-09-30: Other Accrued Liabilities, Current $120.00K.
- 2025-06-30: Other Accrued Liabilities, Current $482.00K.
| Period end | Other Accrued Liabilities, Current | Other Accrued Liabilities, Current as first filed |
|---|---|---|
| 2026-06-30 | $39.00K 10-Q · filed 2026-08-13 | |
| 2025-12-31 | $34.00K 10-Q · filed 2026-08-13 | |
| 2025-09-30 | $120.00K 10-Q · filed 2025-11-10 | |
| 2025-06-30 | $482.00K 10-Q · filed 2025-08-14 | |
| 2025-03-31 | $922.00K 10-Q · filed 2025-05-15 | |
| 2024-12-31 | $1.51M 10-K · filed 2026-03-31 | |
| 2022-12-31 | $88.00K 10-Q · filed 2023-05-10 | |
| 2022-09-30 | $194.00K 10-Q · filed 2022-11-02 | |
| 2022-06-30 | $444.00K 10-Q · filed 2022-08-11 | |
| 2022-03-31 | $702.00K 10-Q · filed 2022-05-12 | |
| 2021-12-31 | $899.00K 10-K · filed 2023-03-15 | $932.00K 10-K · filed 2022-03-08 |
| 2021-09-30 | $1.23M 10-Q · filed 2021-11-08 | |
| 2021-06-30 | $840.00K 10-Q · filed 2021-08-10 | |
| 2021-03-31 | $186.00K 10-Q · filed 2021-05-10 | |
| 2020-12-31 | $643.00K 10-K/A · filed 2022-03-11 | |
| 2020-03-31 | $2.00 10-Q · filed 2020-05-11 | |
| 2019-12-31 | $13.00 10-Q · filed 2020-11-06 | $13.00K 10-K · filed 2020-03-09 |
| 2019-06-30 | $2.00K 10-Q · filed 2019-08-13 | |
| 2019-03-31 | $2.00K 10-Q · filed 2019-05-13 | |
| 2018-12-31 | $31.00K 10-K · filed 2020-03-09 | $32.00K 10-Q · filed 2019-05-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Petros Pharmaceuticals, Inc. (PTPI) | United States | $0.003B | |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| GeoVax Labs, Inc. (GOVX) | United States | $0.003B | -0.45 |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| Silo Pharma, Inc. (SILO) | United States | $0.003B | -1.57 |
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |
| Genprex, Inc. (GNPX) | United States | $0.003B | -0.02 |
| Alaunos Therapeutics, Inc. (TCRT) | United States | $0.003B | -1.44 |
| ORAGENICS INC (OGEN) | United States | $0.002B | |
| Nexentis Technologies Inc. (NXTS) | $0.002B |